Abiratas 250mg 30 Tablet


tablets per bottle: 30; Manufacturer: Intas Pharmaceuticals Ltd


Composition Abiraterone Acetate (250mg)
Primary Use Prostate cancer
cautionPotentially unsafe with Pregnancy Lactation

Medicine Overview of Abiratas Tablet


Uses of Abiratas Tablet

Abiratas 250mg Tablet is used in the treatment of prostate cancer.

Abiratas Tablet side effects


Decreased potassium level in blood, Edema (swelling), Increased blood pressure, Urinary tract infection, Diarrhoea.

How to use Abiratas Tablet

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Abiratas 250mg Tablet is to be taken empty stomach.

How Abiratas Tablet works

Abiraterone acetate belongs to a class drugs known as antiandrogens. It stops the body from making testosterone which can slow the growth of prostate cancer.

In Depth Information on Abiratas Tablet

Expert advice for Abiratas Tablet

  • Abiraterone acetate must be taken at least one hour before or two hours after eating and never with food.
  • Do not break, crush, or chew before swallowing abiraterone acetate tablets.
  • Men who take abiraterone acetate should always use effective birth control measure when having physical relationship with a woman who is or may become pregnant.
  • Contact your doctor if you experience any bone pain. An increased occurrence of bone fractures has been reported in patients using abiraterone acetate.
  • Before you take abiraterone acetate tell your doctor if you have high blood sugar, swelling in the feet, ankles, or legs or any effects on your bones or have taken a medicine known as ketoconazole in the past for prostate cancer.
  • You must inform your doctor or dentist that you take abiraterone acetate before receiving any medical or dental care, emergency care, or surgery.

Abiratas Tablet related warnings

Special precautions for Abiratas Tablet

Interaction with alcohol is unknown. Please consult your doctor.
Abiratas 250mg Tablet is highly unsafe to use during pregnancy. Human and animal studies have shown significant adverse effects on the foetus. Please consult your doctor.
Abiratas 250mg Tablet is unsafe to use during lactation. Data suggests that the drug may cause toxicity to the baby, or the mother is suffering from a condition in which breastfeeding is not advisable.
Abiratas 250mg Tablet does not usually affect your ability to drive.
Abiratas 250mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Abiratas 250mg Tablet is recommended. Because of the limited information, cautious use of Abiratas 250mg Tablet is recommended in patients with severe kidney disease.
Abiratas 250mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Abiratas 250mg Tablet may be needed. Please consult your doctor.

Additional information

Weight 0.13 kg